dotMD.com
Join Community
📖Formal Study Breakdown Talk in Gut, Labs & Supplements Space 711+ Logs • Free →🧮Lab Calculator ↓
Reading this clinical breakthrough? See how real patients are applying these numbers in real life. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
Back to Plain-English 8th-Grade Story
Google Scholar NIH PubMed #42981569
Official NIH NLM MEDLINE / PubMed Citation • PMID: 42981569

Plozasiran for Severe Hypertriglyceridemia and Risk of Pancreatitis

The New England journal of medicine

Verbatim Formal Study Abstract

Among patients with severe hypertriglyceridemia, the use of plozasiran resulted in lower triglyceride levels and a lower risk of acute pancreatitis than placebo at 12 months.